Microbiology and Immunology

You are here

Publications

Found 492 results

Author Title Type [ Year

]

Filters: First Letter Of Last Name is K [Clear All Filters]

2011

Pejchal R, Doores KJ, Walker LM, Khayat R, Huang P-S, Wang S-K, Stanfield RL, Julien J-P, Ramos A, Crispin M et al.. 2011. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield.. Science. 334(6059):1097-103.

Kim J-H, Wei J-R, Wallach JB, Robbins RS, Rubin EJ, Schnappinger D. 2011. Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase.. Nucleic Acids Res. 39(6):2210-20.

Anastassopoulou CG, Ketas TJ, Depetris RS, Thomas AM, Klasse PJohan, Moore JP. 2011. Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41.. Virology. 413(1):47-59.

Anastassopoulou CG, Ketas TJ, Depetris RS, Thomas AM, Klasse PJohan, Moore JP. 2011. Resistance of a human immunodeficiency virus type 1 isolate to a small molecule CCR5 inhibitor can involve sequence changes in both gp120 and gp41.. Virology. 413(1):47-59.

Tsibris AMN, Pal U, Schure AL, Veazey RS, Kunstman KJ, Henrich TJ, Klasse PJ, Wolinsky SM, Kuritzkes DR, Moore JP. 2011. SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses.. PLoS One. 6(12):e28047.

Tsibris AMN, Pal U, Schure AL, Veazey RS, Kunstman KJ, Henrich TJ, Klasse PJ, Wolinsky SM, Kuritzkes DR, Moore JP. 2011. SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses.. PLoS One. 6(12):e28047.

Tsibris AMN, Pal U, Schure AL, Veazey RS, Kunstman KJ, Henrich TJ, Klasse PJ, Wolinsky SM, Kuritzkes DR, Moore JP. 2011. SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses.. PLoS One. 6(12):e28047.

Harris A, Borgnia MJ, Shi D, Bartesaghi A, He H, Pejchal R, Kang YKenneth, Depetris R, Marozsan AJ, Sanders RW et al.. 2011. Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures.. Proc Natl Acad Sci U S A. 108(28):11440-5.

Harris A, Borgnia MJ, Shi D, Bartesaghi A, He H, Pejchal R, Kang YKenneth, Depetris R, Marozsan AJ, Sanders RW et al.. 2011. Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures.. Proc Natl Acad Sci U S A. 108(28):11440-5.

Siracusa MC, Saenz SA, Hill DA, Kim BS, Headley MB, Doering TA, E Wherry J, Jessup HK, Siegel LA, Kambayashi T et al.. 2011. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation.. Nature. 477(7363):229-33.

Siracusa MC, Saenz SA, Hill DA, Kim BS, Headley MB, Doering TA, E Wherry J, Jessup HK, Siegel LA, Kambayashi T et al.. 2011. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation.. Nature. 477(7363):229-33.

Siracusa MC, Saenz SA, Hill DA, Kim BS, Headley MB, Doering TA, E Wherry J, Jessup HK, Siegel LA, Kambayashi T et al.. 2011. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation.. Nature. 477(7363):229-33.

2010

Kaner RJ, Santiago F, Rahaghi F, Michaels E, Moore JP, Crystal RG. 2010. Adenovirus vectors block human immunodeficiency virus-1 replication in human alveolar macrophages by inhibition of the long terminal repeat.. Am J Respir Cell Mol Biol. 43(2):234-42.

Kafsack BFC, Carruthers VB. 2010. Apicomplexan perforin-like proteins.. Commun Integr Biol. 3(1):18-23.

Jiao X, Katiyar S, Willmarth NE, Liu M, Ma X, Flomenberg N, Lisanti MP, Pestell RG. 2010. c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.. J Biol Chem. 285(11):8218-26.

Kafsack BFC, Llinás M. 2010. Eating at the table of another: metabolomics of host-parasite interactions.. Cell Host Microbe. 7(2):90-9.

Banerjee K, Klasse PJ, Sanders RW, Pereyra F, Michael E, Lu M, Walker BD, Moore JP. 2010. IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.. AIDS Res Hum Retroviruses. 26(4):445-58.

Saenz SA, Siracusa MC, Perrigoue JG, Spencer SP, Urban JF, Tocker JE, Budelsky AL, Kleinschek MA, Kastelein RA, Kambayashi T et al.. 2010. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses.. Nature. 464(7293):1362-6.

Saenz SA, Siracusa MC, Perrigoue JG, Spencer SP, Urban JF, Tocker JE, Budelsky AL, Kleinschek MA, Kastelein RA, Kambayashi T et al.. 2010. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses.. Nature. 464(7293):1362-6.

Saenz SA, Siracusa MC, Perrigoue JG, Spencer SP, Urban JF, Tocker JE, Budelsky AL, Kleinschek MA, Kastelein RA, Kambayashi T et al.. 2010. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses.. Nature. 464(7293):1362-6.

Seimon TA, Kim M-J, Blumenthal A, Koo J, Ehrt S, Wainwright H, Bekker L-G, Kaplan G, Nathan C, Tabas I et al.. 2010. Induction of ER stress in macrophages of tuberculosis granulomas.. PLoS One. 5(9):e12772.

Seimon TA, Kim M-J, Blumenthal A, Koo J, Ehrt S, Wainwright H, Bekker L-G, Kaplan G, Nathan C, Tabas I et al.. 2010. Induction of ER stress in macrophages of tuberculosis granulomas.. PLoS One. 5(9):e12772.

Seimon TA, Kim M-J, Blumenthal A, Koo J, Ehrt S, Wainwright H, Bekker L-G, Kaplan G, Nathan C, Tabas I et al.. 2010. Induction of ER stress in macrophages of tuberculosis granulomas.. PLoS One. 5(9):e12772.

Eggink D, Melchers M, Wuhrer M, van Montfort T, Dey AK, Naaijkens BA, David KB, Le Douce V, Deelder AM, Kang K et al.. 2010. Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function.. Virology. 401(2):236-47.

Cheng Y-W, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, Paty P, Barany F. 2010. Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.. Int J Cancer. 127(3):568-77.